Get started
Author

Fumikazu Wanibuchi

Observed names: F. WANIBUCHI, F. Wanibuchi, Fumikazu WANIBUCHI, ワニブチ, フミカズ
OpenAlex ID: A5074996668
Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics
2003 · Yukinori Nagakura, Masamichi Okada, et al. · Journal of Pharmacology and Experimental Therapeutics · 180
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist
2003 · Yasuharu Kimura, Ken-ichi Hatanaka, et al. · European Journal of Pharmacology · 52
Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats
1990 · Fumikazu Wanibuchi, Shinji Usuda · Psychopharmacology · 52
Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies
1994 · Fumikazu Wanibuchi, Takako Nishida, et al. · European Journal of Pharmacology · 40
Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954
1990 · Fumikazu Wanibuchi, Takako Konishi, et al. · European Journal of Pharmacology · 37
Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists
2007 · Itsuro Shimada, Kyoichi Maeno, et al. · Bioorganic & Medicinal Chemistry · 36
Synthesis and Pharmacological Characterization of Novel 6-Fluorochroman Derivatives as Potential 5-HT1A Receptor Antagonists
1998 · Tomoyuki Yasunaga, Takenori Kimura, et al. · Journal of Medicinal Chemistry · 25
Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus
2000 · T. Morita, R. Sonoda, et al. · Psychopharmacology · 22
Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene
1992 · Hongbing Wei, William R. Roeske, et al. · Life Sciences · 22
5-HT2C receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats
2008 · Yasuharu Kimura, Yuki Naitou, et al. · European Journal of Pharmacology · 20
Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa-analogs of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione
1993 · Shinichi Tsukamoto, Masato Ichihara, et al. · Journal of Medicinal Chemistry · 16
Characterization of Intracavernous Pressure Increase Induced by Ym348, a Novel 5-HT 2C Receptor Agonist, in Anesthetized Rats
2006 · Yasuharu Kimura, Yuki Naitou, et al. · The Journal of Urology · 14
Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists
2007 · Itsuro Shimada, Kyoichi Maeno, et al. · Bioorganic & Medicinal Chemistry · 11
Antipsychotics restored but antidepressants and anxiolytics did not restore prepulse inhibition deficits in isolation-reared rats, an animal model of schizophrenia
1997 · Kazuhiro Nakato, Takuma Morita, et al. · The Society for Neuroscience Abstracts · 4
Synthesis and Structure-Activity Studies of a Series of 1-Oxa-2,8-diazaspiro(4.5)decan-3-ones and Related Compounds as M1 Muscarinic Agonists.
1995 · Shin-ichi TSUKAMOTO, Hitoshi NAGAOKA, et al. · Chemical and Pharmaceutical Bulletin · 3
PDF
Corrigendum to “Pharmacological profile of YM348, a novel, potent and orally active 5-HT2c receptor agonist” [Eur. J. Pharmacol. 483 (2004) 37–43]
2004 · Yasuharu Kimura, Ken-ichi Hatanaka, et al. · European Journal of Pharmacology · 1
Effects of a novel muscarinic agonist YM796 on spatial and working memory impairments in rats.
1993 · Hiroshi Yamashita, Fumikazu Wanibuchi, et al. · The Japanese Journal of Pharmacology · 1
PDF
Supraspinal influence on intracavernous pressure increase by subcutaneous injections of MCPP
1998 · Yasuharu Kimura, Fumikazu Wanibuchi, et al. · Neuroscience Research
ChemInform Abstract: Synthesis and Structure‐Activity Studies of a Series of 1‐Oxa‐2,8‐ diazaspiro(4.5)decan‐3‐ones and Related Compounds as M1 Muscarinic Agonists.
1996 · S. TSUKAMOTO, H. NAGAOKA, et al. · ChemInform
ChemInform Abstract: Synthesis and Structure‐Activity Studies of a Series of 1‐Oxa‐8‐ azaspiro(4.5)decanes as M1 Muscarinic Agonists.
1995 · S. TSUKAMOTO, M. FUJII, et al. · ChemInform
ChemInform Abstract: Synthesis and Structure‐Activity Studies of a Series of Spirooxazolidine‐2,4‐diones: 4‐Oxa Analogues of the Muscarinic Agonist 2‐Ethyl‐8‐methyl‐2,8‐diazaspiro(4.5)decane‐1,3‐dione.
1993 · S. TSUKAMOTO, M. ICHIHARA, et al. · ChemInform
Reply to klemm
1993 · F. Wanibuchi, S. Usuda · Psychopharmacology
Anti-amnesic effects of a novel muscarinic agonist, YM796
1993 · F. Wanibuchi, T. Nishida, et al. · Life Sciences
The pharmacological profiles of a novel M1 muscarinic agonist, YM796
1992 · Takako Nishida, Fumikazu Wanibuchi, et al. · The Japanese Journal of Pharmacology
PDF
Effects of dopamine agonistic and anticholinergic agents on catalepsy induced by D-1, D-2, and D-1/D-2 dopamine antagonists in rats
1988 · Fumikazu Wanibuchi, Keiko Hagiwara-Oda, et al. · The Japanese Journal of Pharmacology
PDF
Works count: 27
Citation count: 536
H-index: 12
I10-index: 13
Year
Topic
Type